Skip to main navigation Skip to search Skip to main content

Phase II study of gemcitabine in ovarian cancer

  • G. von Minckwitz
  • , T. Bauknecht
  • , C.M. Visseren-Grul
  • , J.P. Neijt
  • extern
  • University Medical Center Utrecht

Research output: Contribution to journal › Article › Academic › peer-review

Original languageUndefined/Unknown
Pages (from-to)853-855
Number of pages3
JournalAnnals of Oncology
Volume10
Publication statusPublished - 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this